Agilon Health
102 hedge funds and large institutions have $8.68B invested in Agilon Health in 2021 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 50 increasing their positions, 12 reducing their positions, and 23 closing their positions.
317% more repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 12
200% more call options, than puts
Call options by funds: $12.8M | Put options by funds: $4.25M
43% more first-time investments, than exits
New positions opened: 33 | Existing positions closed: 23
11% more funds holding
Funds holding: 92 → 102 (+10)
0.01% more ownership
Funds ownership: 3.38% → 3.4% (+0.01%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
35% less capital invested
Capital invested by funds: $13.3B → $8.68B (-$4.61B)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$147M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$138M |
| 3 |
Capital World Investors
Los Angeles,
California
|
+$111M |
| 4 |
Capital Research Global Investors
Los Angeles,
California
|
+$92.8M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$46.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CDR
Clayton Dubilier & Rice
New York
|
-$641M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$21.4M |
| 3 |
DKCM
Davidson Kempner Capital Management
New York
|
-$19.3M |
| 4 |
AG
Artal Group
Luxembourg
|
-$12.2M |
| 5 |
DM
Deerfield Management
New York
|
-$12.2M |
AGL Hedge Fund Activity: Q3 2021 in Review
102 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in Agilon Health (AGL) for Q3 2021, worth a combined $8.68B — down 35% from $13.3B a quarter earlier.
Buyers outnumbered sellers: 33 funds opened new AGL positions and 23 closed out — a net gain of 10 holders — while 50 added to existing stakes and 12 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $147M. The largest seller was Clayton Dubilier & Rice, cutting an estimated $641M.
- 102 institutional investors held Agilon Health (AGL) as of Q3 2021, up from 92 in Q2 2021.
- Funds reported $8.68B of Agilon Health stock for Q3 2021, down 35% quarter-over-quarter.
- 33 funds opened new Agilon Health positions in Q3 2021 and 23 closed out, a net change of +10 holders.
- The largest Agilon Health buyer in Q3 2021 was Fidelity Investments, an estimated $147M added.
- The largest Agilon Health seller in Q3 2021 was Clayton Dubilier & Rice, an estimated $641M sold.
Based on aggregated 13F filings for Q3 2021.